How Vitamin D Receptor Influences Intestinal Barrier Functions
维生素 D 受体如何影响肠道屏障功能
基本信息
- 批准号:9893864
- 负责人:
- 金额:$ 41.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-01 至 2022-03-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAnimal ModelAreaAttenuatedBacterial InfectionsBiological AssayBiologyChronicClinicalCommunicable DiseasesDataDigestive System DisordersDown-RegulationEnsureEnteralEpithelialEpitheliumFood ContaminationGastroenterologistGenesGoalsHomeostasisImpairmentIn VitroInfectionInflammationIntestinal permeabilityIntestinesKnowledgeLaboratoriesLeadLinkMicrobeMicrobiologyMolecularMucositisMucous MembraneMusOrganoidsPathogenesisPathogenicityPermeabilityPhysiologicalPlayProbioticsProteinsPublic HealthPublicationsRegulationResearchResearch PersonnelResistanceRoleSalmonellaSalmonella entericaSalmonella infectionsSerotypingSeveritiesSourceStructureTechnologyTestingTight JunctionsTissuesTracerTransgenic MiceTransgenic ModelTransgenic OrganismsVitamin DVitamin D Response ElementVitamin D3 ReceptorWaterbaseconditional knockoutdesignenteric pathogengain of functioninnovationinsightintestinal barrierintestinal epitheliumlactic acid bacterialoss of functionmouse modelnew therapeutic targetnoveloccludinpathogenpreventpromoterreceptorreceptor expressionreceptor functionrepairedresponsetool
项目摘要
Impaired intestinal barriers are associated with infection. Vitamin D and its receptor (VDR) levels are inversely
related to chronic inflammation in infectious diseases. Salmonella enterica serotypes are invasive enteric
pathogens spread through fecal contamination of food and water sources, and represent a constant public
health threat in US and around the world. The objective of this application is to study VDR regulation of
intestinal tight junctions (TJs) in response to Salmonella infection. Salmonella induces the disruption of TJs
during infection. This is associated with a decrease in trans-epithelial resistance, increase in tracer
permeability, and TJ protein alterations. Our publications and preliminary data have shown that: (1) lack of
VDR makes the host susceptible to Salmonella invasion; (2) Salmonella targets TJ proteins (e.g. ZO-1, Claudin)
and facilitates pathogenic enteric bacterial invasion. (3) We have identified the sequence of functional vitamin
D response element in Claudin 5, a potential novel target gene of VDR; (4) impaired VDR leads to reduced
expression of TJ proteins, abnormal TJ structure, and increased intestinal permeability in infection; and (5)
probiotics enhance VDR function and inhibit Salmonella infection. Thus, we hypothesize that: “intestinal
epithelial VDR regulation of barrier function is aberrant or lost in infectious states, and restoring VDR function
will attenuate infection and chronic inflammation.” We have now developed state-of-the-art transgenic models,
e.g. intestinal epithelial VDR conditional knockout (VDR∆IEC) mice, conditional transgenic VDR over-expressing
(Tg-VDR) mice, along with loss- and gain- function assays of VDR in organoids to investigate VDR actions that
critically affect barrier functions of the intestine.
Aim 1. Determine the molecular mechanism by which intestinal VDR regulates barrier function that is
essential for mucosal homeostasis. We will elucidate the mechanism for abnormal epithelial TJs in the VDR-/-
organoids and VDR∆IEC mice.
Aim 2. Determine the mechanisms by which impaired intestinal barrier is associated with severe infection
in VDR∆IEC mice. We will determine the physiological role and molecular mechanism of intestinal epithelial VDR,
as an upstream regulator, in linking TJs in the VDR∆IEC mice with Salmonella infection.
Aim 3. Restore the intestinal epithelial VDR expression by force expression of VDR or probiotic treatment
to alleviate infection and associated inflammation. We will determine the roles and mechanisms of A) forced
intestinal epithelial VDR expression in restoring TJ integrity in Salmonella infected Tg-VDR mice; and B)
enhanced intestinal VDR expression by probiotic lactic acid bacteria in infected mice. This knowledge can then
be exploited to define strategies to prevent and treat pathogen infection, by restoring intestinal VDR.
受损的肠壁与感染有关。维生素D及其接收器(VDR)水平是成反比的
与慢性感染感染疾病有关。沙门氏菌肠道种型是侵入性肠
病原体通过食物和水源的粪便污染传播,并代表不断的公众
我们和世界各地的健康威胁。该应用的目的是研究
肠道紧密连接(TJ)响应沙门氏菌感染。沙门氏菌诱导TJ的破坏
在感染期间。这与跨上皮电阻的降低有关,示踪剂增加
渗透性和TJ蛋白改变。我们的出版物和初步数据表明:(1)缺乏
VDR使宿主容易受到沙门氏菌入侵的影响; (2)沙门氏菌靶标TJ蛋白(例如ZO-1,Claudin)
并促进致病启动子细菌侵袭。 (3)我们已经确定了功能性维生素的序列
D响应元件在Claudin 5(VDR的潜在新型靶基因)中; (4)VDR受损导致减少
TJ蛋白的表达,异常TJ结构和感染中肠渗透性的增加; (5)
益生菌增强了VDR功能并抑制沙门氏菌感染。那就是我们假设的:“肠道
屏障功能的上皮VDR调节在感染状态中是异常或损失的,并恢复VDR功能
将减弱感染和慢性感染。“我们现在已经开发了最先进的转基因模型,
例如肠上皮VDR条件敲除(VDRΔIEC)小鼠,有条件的转基因VDR过表达
(TG-VDR)小鼠,以及类器官中VDR的损耗和增益功能测定,以研究VDR作用
严重影响肠的屏障功能。
目标1。确定肠道VDR调节屏障功能的分子机制
对于粘膜稳态至关重要。我们将阐明VDR - / - 中异常上皮TJ的机制
器官和VDRΔIEC小鼠。
AIM 2。确定受损肠壁与严重感染有关的机制
在vdrΔiec小鼠中。我们将确定肠上皮VDR的身体作用和分子机制,
作为上游调节剂,将VDRΔIEC小鼠中的TJ与沙门氏菌感染联系起来。
AIM 3。通过VDR或益生菌处理的力表达恢复肠上皮VDR表达
减轻感染和相关感染。我们将确定A)强迫的作用和机制
肠道上的TJ完整性在感染的TG-VDR小鼠中恢复TJ完整性中的肠上皮VDR表达;和b)
益生菌乳酸菌在感染小鼠中通过益生菌乳酸细菌增强了肠道VDR。然后这些知识可以
探索以通过恢复肠道VDR来定义预防和治疗病原体感染的策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jun Sun其他文献
Comment on “New predictive scheme for the control of LTI systems with input delay and unknown disturbances [Automatica 52 (2015) 179–184]”
对“具有输入延迟和未知干扰的 LTI 系统控制的新预测方案 [Automatica 52 (2015) 179–184]”的评论
- DOI:
10.1016/j.automatica.2020.108979 - 发表时间:
2020 - 期刊:
- 影响因子:6.4
- 作者:
Jun Sun - 通讯作者:
Jun Sun
Jun Sun的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jun Sun', 18)}}的其他基金
Vitamin D Receptor Regulation of Microbiota in Intestinal Epithelia
维生素 D 受体对肠上皮微生物群的调节
- 批准号:
10736407 - 财政年份:2023
- 资助金额:
$ 41.37万 - 项目类别:
Microbiome and intestinal barrier in ALS therapy
ALS 治疗中的微生物组和肠道屏障
- 批准号:
10454789 - 财政年份:2020
- 资助金额:
$ 41.37万 - 项目类别:
Microbiome and intestinal barrier in ALS therapy
ALS 治疗中的微生物组和肠道屏障
- 批准号:
10618861 - 财政年份:2020
- 资助金额:
$ 41.37万 - 项目类别:
Microbiome and intestinal barrier in ALS therapy
ALS 治疗中的微生物组和肠道屏障
- 批准号:
9884176 - 财政年份:2020
- 资助金额:
$ 41.37万 - 项目类别:
How Vitamin D Receptor Influences Intestinal Barrier Functions
维生素 D 受体如何影响肠道屏障功能
- 批准号:
9791827 - 财政年份:2018
- 资助金额:
$ 41.37万 - 项目类别:
Vitamin D Receptor Regulation of Microbiota in Intestinal Epithelia
维生素 D 受体对肠上皮微生物群的调节
- 批准号:
9197981 - 财政年份:2016
- 资助金额:
$ 41.37万 - 项目类别:
Enteric bacterial modulation of Vitamin D Receptor signaling in colitis
结肠炎中维生素 D 受体信号传导的肠道细菌调节
- 批准号:
8470002 - 财政年份:2012
- 资助金额:
$ 41.37万 - 项目类别:
Enteric bacterial modulation of Vitamin D Receptor signaling in colitis
结肠炎中维生素 D 受体信号传导的肠道细菌调节
- 批准号:
8112427 - 财政年份:2010
- 资助金额:
$ 41.37万 - 项目类别:
Enteric bacterial modulation of Vitamin D Receptor signaling in colitis
结肠炎中维生素 D 受体信号传导的肠道细菌调节
- 批准号:
7959275 - 财政年份:2010
- 资助金额:
$ 41.37万 - 项目类别:
NF-kB /Beta-catenin interaction during intestinal inflammation
肠道炎症期间 NF-kB /β-catenin 相互作用
- 批准号:
7906796 - 财政年份:2007
- 资助金额:
$ 41.37万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
- 批准号:82300396
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
- 批准号:32370568
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
- 批准号:82360332
- 批准年份:2023
- 资助金额:31.00 万元
- 项目类别:地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
- 批准号:82303057
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Childhood trauma, hippocampal function, and anhedonia among those at heightened risk for psychosis
精神病高危人群中的童年创伤、海马功能和快感缺失
- 批准号:
10825287 - 财政年份:2024
- 资助金额:
$ 41.37万 - 项目类别:
Novel application of pharmaceutical AMD3100 to reduce risk in opioid use disorder: investigations of a causal relationship between CXCR4 expression and addiction vulnerability
药物 AMD3100 降低阿片类药物使用障碍风险的新应用:CXCR4 表达与成瘾脆弱性之间因果关系的研究
- 批准号:
10678062 - 财政年份:2023
- 资助金额:
$ 41.37万 - 项目类别:
Mechanisms of Metal Ion Homeostasis of Oral Streptococci
口腔链球菌金属离子稳态机制
- 批准号:
10680956 - 财政年份:2023
- 资助金额:
$ 41.37万 - 项目类别:
Design and testing of a novel circumesophageal cuff for chronic bilateral subdiaphragmatic vagal nerve stimulation (sVNS)
用于慢性双侧膈下迷走神经刺激(sVNS)的新型环食管套囊的设计和测试
- 批准号:
10702126 - 财政年份:2023
- 资助金额:
$ 41.37万 - 项目类别:
Project 2: Informing oral nicotine pouch regulations to promote public health
项目 2:告知口服尼古丁袋法规以促进公共卫生
- 批准号:
10666068 - 财政年份:2023
- 资助金额:
$ 41.37万 - 项目类别: